Yale School of Medicine researchers have identified a biomarker panel that improves the assessment of chronic kidney disease (CKD) progression...
Biomarker
The global renal biomarker market is experiencing remarkable growth, driven by increasing prevalence of chronic kidney diseases (CKD) and advancements...
